21.2 C
Munich
Friday, March 29, 2024
- Advertisement -
- Advertisement -spot_img

TAG

Therapeutics

Marker Therapeutics Stories Fiscal 12 months 2021 Working and Monetary Outcomes

Enrollment of first 20 sufferers of the Firm’s Section 2 acute myeloid leukemia (AML) trial accomplished in This fall 2021Topline readout of Group...

Virios Therapeutics Pronounces Fourth Quarter and Full 12 months 2021 Monetary Outcomes and Gives Company Replace

- Prime line Information from Part 2b FORTRESS Examine of IMC-1 on Monitor for Q3 2022 -- Pipeline Expanded with IMC-2 as Therapy...

Juniper Analysis: Digital Therapeutics Income from Well being Insurers to Attain $8 Billion Globally by 2026

BASINGSTOKE, England--(BUSINESS WIRE)--A brand new examine from Juniper Analysis has discovered digital therapeutics income from...

Nevada emphasizes therapeutics as new COVID-19 instances plummet | Well being and Health

RENO, Nev. (AP) — As Nevada's COVID-19 case charges plummet to their lowest ranges since final summer season, state well being officers are...

Sabal Therapeutics Declares Gross sales and Advertising Settlement to Promote Athena Bioscience Cardiovascular Product Portfolio

ATHENS, Ga., Feb. 22, 2022 /PRNewswire/ -- Sabal therapeutics, LLC introduced right this moment that they've entered into an unique gross sales and advertising...

International Blood Therapeutics Will get European Advertising and marketing Authorization for Oxbryta

By Chris Wack International Blood Therapeutics Inc. mentioned Wednesday that the European Fee has...

Serious about shopping for inventory in BioDelivery Sciences, China On-line Schooling, Gold Fields, Y-mAbs Therapeutics, or Bloom Vitality?

NEW YORK, Feb. 14, 2022 /PRNewswire/ -- InvestorsObserver points essential PriceWatch Alerts for BDSI, COE, GFI, YMAB, and BE. To see how InvestorsObserver's proprietary scoring system...

TreeFrog Therapeutics Secures $75m In Series B Financing To Advance A Pipeline Of Stem Cell-Derived Cell Therapies And Deploy Proprietary C-Stem™ Technology In The...

Frederic Desdouits, PhD, named chief executive officer. Co-founder Kevin Alessandri, PhD, relocates to Boston to drive TreeFrog Therapeutics' expansion in the U.S.BORDEAUX, France,...

Latest news

- Advertisement -spot_img